NASDAQ
4.82USD
-0.31 (-6.04%)
We have scored 4 news catalysts on DarioHealth Corp. (DRIO) over the past 12 months. The biggest single-day move next to one of them came Oct 29, 2025, when DRIO closed −8.3%: “SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of DarioHealth Corp. (NASDAQ: DRIO)”. Coverage across the window leans mixed (average ticker sentiment −0.05). Most of the impact sits in institutional appeal and downstream customer concentration.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
47.2M
P/E
—
EPS
—
Beta
1.18
52W range
4.82-16.5
Day range
4.82–5.40
Open
5.33
Prev close
5.13
Volume
26.3K
Avg volume
21.5K
Dividend
0.00
IPO
2016-03-14
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about DarioHealth Corp. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for DRIO: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
